Skin disorders in peritoneal dialysis patients: An underdiagnosed subject

Table 1 Biochemical and hematological laboratory data of the patients

Parameter	Mean ± SD	Parameter	Mean ± SD
Hemoglobin (g/dL)	10.9 ± 1.3	Phosphorus (mg/dL)	4.7 ± 1.0
Hematocrit (%)	32 ± 3	Parathyroid hormone (pg/mL)	600 ± 502
Ferritin (ng/dL)	288 ± 294	Alkaline phosphatase (U/L)	180 ± 342
Transferrin saturation (%)	25 ± 10	Alanine transaminase (U/L)	12.8 ± 5.4
Total protein (g/dL)	6.9 ± 0.5	Aspartate transaminase (U/L)	16.2 ± 6.6
Albumin (g/dL)	3.5 ± 0.3	Total bilirubin (mg/dL)	0.5 ± 0.4
Uric acid (mg/dL)	5.6 ± 1.0	Direct bilirubin (mg/dL)	0.1 ± 0.02
Calcium (mg/dL)	8.9 ± 0.6	Gamma glutamyl transferase (U/L)	24.8 ± 22.4

Table 2 The medications used by the patients

Drug	n (%)	Drug	n (%)
Calcium-containing phosphorus binders	27 (71)	Alpha blockers	6 (16)
Diuretics	25 (66)	Acetylsalicylic acid	6 (16)
Active vitamin D	21 (55)	RAS blockers	5 (13)
Erythropoiesis stimulating agents	20 (53)	Cinecalcet	5 (13)
Calcium channel blockers	18 (47)	Allopurinol	3 (7)
Beta blockers	13 (34)	Fibrates	1 (2.6)
Statins	14 (37)	Sevalemer	1 (2.6)
Essential amino acid	10 (26)

RAS: Renin-angiootensin-aldosteron system.

Table 3 The skin findings of the patients

Lesion	n (%)	Lesion	n (%)
Loss of lunula	17 (44.7)	Koilonychia	1 (2.6)
Onychomycosis	16 (42.1)	Pigmented purpuric dermatosis	1 (2.6)
Tinea pedis	15 (39.5)	Neurodermitis	1 (2.6)
Xeroderma cutis	14 (36.8)	Prurigo nodularis	1 (2.6)
Hyperpigmentation	11 (28.9)	Splinter hemorrhage	1 (2.6)
Nevus	6 (15.8)	Subungual hyperkeratosis	1 (2.6)
Acne	4 (10.5)	Verruca vulgaris	1 (2.6)
Uremic pruritus	3 (8.1)	Vitiligo	1 (2.6)
Contact dermatitis	2 (5.3)	Half and half nail	1 (2.6)
Folliculitis	2 (5.3)	Acne rosacea	1 (2.6)
Chronic eczema	1 (2.6)